Rationale for the USPSTF recommendation on screening for glaucoma

American Family Physician

Volumn 72, Issue 7, 2005, Pages 1184-1186

  Guirguis Blake, Janelle ^a   Janelle Guirguis Blake, M D ^a  

^a AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL EXAMINATION; CLINICAL FEATURE; DIAGNOSTIC TEST; EDITORIAL; GLAUCOMA; HUMAN; LITERATURE; MEDICAL INFORMATION; OPEN ANGLE GLAUCOMA; OPHTHALMOSCOPY; PREVENTIVE MEDICINE; SCREENING TEST; VISION; VISUAL FIELD; MASS SCREENING; PRACTICE GUIDELINE; STANDARD; TREATMENT OUTCOME; VISUAL DISORDER;

GLAUCOMA; HUMANS; MASS SCREENING; PRACTICE GUIDELINES; TREATMENT OUTCOME; VISION DISORDERS;

EID: 27744606520     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Editorial

References (5)

1. U.S. Preventive Services Task Force. Screening for glaucoma: recommendation statement. Ann Fam Med 2005; 3:171-2.
2. Fleming C, Whitlock EP, Beil T, Smit B, Harris RP. Screening for primary open-angle glaucoma in the primary care setting: an update for the U.S. Preventive Services Task Force. Ann Fam Med 2005;3:167-70.
3. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701-13.
4. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group [published correction appears in Am J Ophthalmol 1999;127:120]. Am J Ophthalmol 1998;126:487-97.
5. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002;120:1268-79.